SCHEMBL13661931

SCHEMBL13661931

COC[C@H]1C[C@H](OS(C)(=O)=O)CN1B(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13661946 0.82 — —
SCHEMBL13661938 0.80 SCN3A (0.34) —
SCHEMBL13661915 0.77 — —
SCHEMBL13661930 0.77 — —
SCHEMBL3249508 0.75 MMP2 (0.35) —
SCHEMBL26086744 0.75 MMP2 (0.35) —
SCHEMBL3945766 0.75 MMP2 (0.35) —
SCHEMBL14367083 0.74 MMP2 (0.43) —
SCHEMBL1439343 0.74 — —
SCHEMBL1439651 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264431-A1 NOVEL CATHEPSIN C INHIBITORS AND THEIR USE GLAXO GROUP LIMITED (GB) 2009-10-22 — — US disclosed
Send feedback